News About: R&D


Overlapping Investment of Government to Bio Industry

Government's policy to foster bio industry to leap to world best 7 countries with strong bio industry is pointed out having problem such as overlapping investment by related agencies, short-term investment and random ...

Basic research for new drugs needs government subsidy.

The government subsidy over the pharmaceutical industry has supported more to commercialization of new products rather than the R&D for a new drug discovery without consideration of the national pharmaceutical technol...

Expanded Support to Health Industry Including New Medicine Development

The Ministry of Health and Welfare decided on a policy to push forward the Bio Public Health Technology Development Industry to enhance the competitiveness of the biotechnology sector while reinforcing new medicine de...

Government is supportive of the development of biotechnology

With the increasing national attention being focused on the bio-industry, its future seems bright as concerned government agencies continue to support the development of the BT industry along with the active preventio...

7 companies filed 13 new drugs in first half of the year.

7 drug companies applied the health registration to the KFDA for 13 new drugs during the first half of this year. During the first quarter of this year, the total 7 new drugs filed; LG chemical filed Ace Chole 1, 2...

3 new drugs of domestic origin under clinical phase III studies.

3 new compounds discovered by domestic drug companies are on the clinical phase III studies, showing its commercialization very soon. The KFDA said that 3 new drugs included Apitoxin inj. (Kuju) for the treatment o...

Pressing financial resource for new medicine development

KPMA insisted that reimbursement system of actual market price should be come to stay and low-profit structure should be improved for the purpose of preventing unreasonable price from reducing and settling orderly med...

New drug R&D investment by conglomerates near to reap.

Many conglomerates who entered into the pharmaceutical business seem to harvest soon their investment for an R&D of new drug discovery. LG, SK and Cheiljedang already committ...

SNU Pharmaceutical College give 4.5 SCI Theses per capita

Seoul National University pharmaceutical college professors are appeared to superior research performance to other college by 4.5 theses registrated in SCI(Science Citation Index) last year. According to its own m...

Anticancer drug expected to realize the 'Personalized anticancer treatment'

A prospect for the realization of the 'Personalized anticancer treatment', by which cancer prevention, diagnosis, anticancer drug choice, and medication time can be arranged for the patient, came out. The examiner...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.